712
Views
6
CrossRef citations to date
0
Altmetric
Perspectives

Clopidogrel, prasugrel, ticagrelor or vorapaxar in patients with renal impairment: do we have a winner?

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Raphaëlle-Ashley Guerbaai, Indrajeet Mahata, Sylvestre Maréchaux, Thierry H. Le Jemtel & Pierre-Vladimir Ennezat. (2019) Is ticagrelor worth its high cost and side-effects?. Acta Cardiologica 74:2, pages 93-98.
Read now

Articles from other publishers (5)

Sigrid E. Sandner, Heribert Schunkert, Adnan Kastrati, Milan Milojevic, Andreas Böning, Daniel Zimpfer, Stephan Zellmer, Dominik Wiedemann, Günther Laufer & Moritz von Scheidt. (2022) Ticagrelor or Aspirin After Coronary Artery Bypass in Patients With Chronic Kidney Disease. The Annals of Thoracic Surgery 113:2, pages 554-562.
Crossref
Michael Spartalis, Eleni Tzatzaki, Eleftherios Spartalis, Stavroula A Paschou, Antonios Athanasiou, Dimitrios C Iliopoulos, Gerasimos Siasos & Vassilis Voudris. (2020) Prasugrel in the treatment of acute coronary syndrome. Future Cardiology 16:6, pages 559-568.
Crossref
Madhumita Chatterjee, Agnes Ehrenberg, Laura Mara Toska, Lisa Maria Metz, Meike Klier, Irena Krueger, Friedrich Reusswig & Margitta Elvers. (2020) Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy. International Journal of Molecular Sciences 21:21, pages 7906.
Crossref
Kai Chang, Zhongyong Jiang, Chenxia Liu, Junlong Ren, Ting Wang & Jie Xiong. (2016) The Effects of CYP2C19 genotype on the susceptibility for nephrosis in cardio-cerebral vascular disease treated by anticoagulation. Medicine 95:38, pages e4954.
Crossref
Long Zhe Guo, Moo Hyun Kim, Tae Hyung Kim, Jong Seong Park, Enze Jin, Chang Heon Shim, Sun Young Choi & Victor L. Serebruany. (2016) Comparison of Three Tests to Distinguish Platelet Reactivity in Patients with Renal Impairment during Dual Antiplatelet Therapy. Nephron 132:3, pages 191-197.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.